(Press-News.org) WASHINGTON (June 11, 2013) —Researcher Michael S. Irwig, M.D., F.A.C.E., assistant professor of medicine at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) and director of the Center for Andrology at The GW Medical Faculty Associates, found that men who used the medication finasteride (Propecia) and developed persistent sexual side effects, are also drinking less alcohol than before.
This research will be published in the journal, Alcoholism: Clinical & Experimental Research. While robust literature exists on the interaction between finasteride and alcohol in rodents, this is the first study to examine the role of finasteride in alcohol consumption in humans with male pattern hair loss. The findings from this research are consistent with the findings from research in rodents, identifying that finasteride has the ability to modulate alcohol intake.
"Finasteride use leads to decreased concentrations of important hormones in the brain called neurosteroids. Because this is a preliminary report, further research is needed on the effects of finasteride in the human brain," said Irwig. "This is an important step towards better understanding the breadth of side effects in humans from the drug finasteride."
Irwig administered standardized interviews to 83 otherwise healthy men who developed persistent sexual side effects associated with finasteride, despite the cessation of this medication for at least three months. Information regarding medical histories, sexual function, and alcohol consumption before and after taking finasteride was collected. Of the 63 men who consumed at least one alcoholic drink per week prior to starting finasteride, 41 men (65 percent) noted a decrease in their alcohol consumption after stopping finasteride. Twenty men (32 percent) reported no change in their alcohol consumption and two men (3 percent) reported an increase in alcohol consumption.
###
For a copy of the study, or to speak with Dr. Irwig about his research, please contact Lisa Anderson at lisama2@gwu.edu or 202-994-3121.
About the GW School of Medicine and Health Sciences
Founded in 1825, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation's capital and is the 11th oldest in the country. Working together in our nation's capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. http://www.smhs.gwu.edu
GW researcher finds association between finasteride and decreased levels of alcohol consumption
2013-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Austerity cuts to Spanish healthcare system are 'putting lives at risk'
2013-06-13
A series of austerity reforms made by the Spanish government could lead to the effective dismantling of large parts of the country's healthcare system, with potentially detrimental effects on the health of the Spanish people, according to new research published in BMJ.
National budget cuts of 13.65% (€365m) and regional budget cuts of up to 10% to health and social care services in 2012 have coincided with increased demands on the health system, particularly affecting the elderly, disabled and those with poor mental health. The authors, led by the London School of Hygiene ...
Volunteering reduces risk of hypertension in older adults, Carnegie Mellon research shows
2013-06-13
PITTSBURGH—It turns out that helping others can also help you protect yourself from high blood pressure.
New research from Carnegie Mellon University shows that older adults who volunteer for at least 200 hours per year decrease their risk of hypertension, or high blood pressure, by 40 percent. The study, published by the American Psychological Association's Psychology and Aging journal, suggests that volunteer work may be an effective non-pharmaceutical option to help prevent the condition. Hypertension affects an estimated 65 million Americans and is a major contributor ...
Gene variants may predict who will benefit from breast cancer prevention drugs
2013-06-13
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
The work represents a major step toward truly individualized breast cancer prevention in women at high risk for the disease based on their age, family history of breast cancer, and personal medical history.
"Our study reveals the first known genetic factors ...
Oysters could rebound more quickly with limited fishing and improved habitat
2013-06-13
SOLOMONS, MD (June 13, 2013)—A new study shows that combining improved oyster restoration methods with limits on fishing in the upper Chesapeake could bring the oyster population back to the Bay in a much shorter period of time. The study led by Michael Wilberg of the University of Maryland Center for Environmental Science's Chesapeake Biological Laboratory assessed a range of management and restoration options to see which ones would have the most likelihood success.
"This new model we developed suggests that oysters should be able to come back if we help them out ...
First major study of suicide motivations to advance prevention
2013-06-13
A University of British Columbia study sheds important new light on why people attempt suicide and provides the first scientifically tested measure for evaluating the motivations for suicide.
Published in the official journal of the American Association of Suicidology, the work gives doctors and researchers important new resources to advance suicide prevention, improve treatments, and reduce the likelihood of further attempts.
"Knowing why someone attempted suicide is crucial – it tells us how to best help them recover," says Prof. David Klonsky, UBC Dept. of Psychology. ...
World population could be nearly 11 billion by 2100, UW research shows
2013-06-13
A new statistical analysis shows the world population could reach nearly 11 billion by the end of the century, according to a United Nations report issued June 13. That's about 800 million, or about 8 percent, more than the previous projection of 10.1 billion, issued in 2011.
The projected rise is mostly due to fertility in Africa, where the U.N. had expected birth rates to decline more quickly than they have.
"The fertility decline in Africa has slowed down or stalled to a larger extent than we previously predicted, and as a result the African population will go ...
50 percent of rheumatoid arthritis patients discontinue medication within the first 2 years
2013-06-13
Madrid, Spain, 13 June 2013: Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that up to one-third of rheumatoid arthritis (RA) patients discontinue or change therapy within the first year of treatment.
Loss of efficacy was the most common reason given (35.8%), followed by safety (20.1%), physician or patient preference (27.8% and 17.9%, respectively) and access to treatment (9.0%). Rates and rationale for treatment discontinuation were similar for both tumour necrosis factor inhibitors (TNFi) and non-TNFi biologics.
RA ...
Childbirth increases risk of ACPA-negative rheumatoid arthritis
2013-06-13
Madrid, Spain, 13 June 2013: Epidemiological data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that pregnancy carried to childbirth (parity) increases the risk of ACPA-negative* rheumatoid arthritis (RA).
The increased risk was demonstrated in women aged 18-44 who have had a child (2.1, 95% CI 1.4-3.2), but not in older women, and was more pronounced among those women with delivery during the first year of symptoms.
RA is an autoimmune disease characterised by inflammation of the joints and tendons. As a ...
Canakinumab allows discontinuation of corticosteroids in patients with SJIA
2013-06-13
Madrid, Spain, 13 June 2013: Study findings first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate the efficacy of canakinumab at tapering corticosteroid (CS) use in patients with SJIA.
Successful CS tapering was achieved within 20 weeks in almost half of patients (44.5%, p END ...
Depression indicators predict work disabilty more than disease activity or response to therapy
2013-06-13
Madrid, Spain, 13 June 2013: Data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that indicators of depression are stronger predictors of work disability in early arthritis than disease activity or response to therapy.
The study showed that in a multivariable analysis none of the arthritis activity measures or cardiovascular, metabolic or pulmonary diseases investigated were associated with early retirement, yet a single depression statement "having little pleasure or interest in doing things most of the days ...